References
- Supino PG, Borer JS, Preibisz J, Bornstein A. The epidemiology of valvular heart disease: a growing public health problem. Heart Fail Clin 2006;2:379–93.
- Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142–7.
- Akat K, Borggrefe M, Kaden JJ. Aortic valve calcification: basic science to clinical practice. Heart 2009;95:616–23.
- Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316–26.
- Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction: Universal definition of myocardial infarction. Eur Heart J 2007;28:2525–38.
- Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363–9.
- Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease. Adv Clin Chem 2005;40:1–36.
- Zethelius B, Berglund L, Sundstrøm J, Ingelsson E, Basu S, Larsson A, . Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358:2107–16.
- Galante A, Pietroiusti A, Vellini M, Piccolo P, Possati G, De Bonis M, . C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078–82.
- Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, Hamm C. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 2005;26:1023–30.
- Skjaerpe T, Hegrenaes L, Hatle L. Noninvasive estimation of valve area in patients with aortic stenosis by Doppler ultrasound and two-dimensional echocardiography. Circulation 1985;72:810–8.
- Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, . Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography: Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–63.
- Ortlepp JR, Schmitz F, Bozoglu T, Hanrath P, Hoffmann R. Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pairmatched case-control study. Heart 2003;89:1019–22.
- Weber M, Hausen M, Arnold R, Nef H, Moellman H, Berkowitsch A, . Prognostic value of N-terminal pro- B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis. Heart 2006;92:1639–44.
- Lim P, Monin JL, Monchi M, Garot J, Pasquet A, Hittinger L, . Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 2004;25:2048–53.
- Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, . Val-HeFT Investigators: prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242–9.
- Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, . Prevention of events with angiotensin converting enzyme inhibition (PEACE) trial investigators prevention of events with angiotensin converting enzyme inhibition (PEACE) trial investigators: A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538–47.
- Røsjø H, Andreassen J, Edvardsen T, Omland T. Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. Am J Cardiol 2011;108:88–91.
- Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, . Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109:2302–8.
- Novaro GM, Katz R, Aviles RJ, Gottdiener JS, Cushman M, Psaty BM, . Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007;50:1992–8.